Better Board Governance in Challenging Times: What Makes the Difference?
By Laureen DeBuono
(with contributing author Jeff Kuhn) Laureen DeBuono is currently Lead Independent Board Director at Rani Therapeutics (NASDAQ: RANI), and Jeff Kuhn is currently Chair of the Audit Committee and on the board at Skyline Enterprises. Both FLG partners have served as past directors and Committee Chairs at a number of…Read More
Read More